This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Chiali Liu, PhD
Sr Director, Drug Substance Process Development Biologics CMC at Teva Pharmaceuticals


Chiali Liu is Senior Director of Drug Substance Process Development, Biologics CMC at Teva Pharmaceuticals, overseeing upstream and downstream process development of biologic drug substance, technology transfer, and Material Sciences functions.

She obtained Ph.D. in Chemical Engineering at MIT.

She has more than 20 years’ experience in process development, scale-up, technology transfer, clinical and commercial production of biologics, plus technology transfer and commercialization of advanced therapy.  She worked at Janssen, GSK, Human Genome Sciences, and Centocor before joining Teva.

Agenda Sessions

  • Improving campaign readiness process for clinical production